SciELO - Scientific Electronic Library Online

 
vol.48 número2Quimioterapia metronómica con ciclofosfamida y metotrexato en pacientes con cáncer de mama metastásico en progresiónComorbilidad y mortalidad en una cohorte de pacientes cubanos con artritis reumatoide índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Medicina

versión impresa ISSN 0034-7523versión On-line ISSN 1561-302X

Resumen

SORIANO GARCIA, Jorge L et al. Paclitaxel-carboplatine scheme assessment applied in patients presenting with metastatic breast cancer. Rev cubana med [online]. 2009, vol.48, n.2. ISSN 0034-7523.

Introduction: Paclitex chemotherapy is essential in metastatic breast cancer (MBC). We assessed effectiveness and safety of combined use of carboplatine. Methods: We made a descriptive and retrospective study of 63 patients treated in Oncology Service of "Hermanos Ameijeiras" Surgical Clinical Hospital from January, 2001 to December, 2005 with a histological confirmation of breast cancer, and metastatic disease, previously treated with anthracyclins (in adjuvant therapy). Results: There was a predominance of negative hormonal receptors, and presence of an only metastatic site. Bone and lungs were the more common metastatic locations, 26.4 % and 21.8 %, respectively. Global response rate was of 33.3 %. There were not significant differences in response rate by prognostic variables. Survival at 1, 2, ant 3 years was of 60, 46.4 and 28.2 %, respectively. Survival average was of 16,2 months. Variables associated with a better prognosis were a Karnofsky rate ³ 60 %, positive hormonal receptors and presence of an only metastatic site. Disease disseminated in bone, soft tissues, and skin had a better prognosis. Main toxicities were: hematologic, neurologic, and digestives. The adverse processes average by patient was of 2.6 and the 20 % of these ones were 3-4 degrees. Increment in hepatic enzymes caused a higher level of treatment suspension. Conclusions: Combined schemes with Paclitaxel have a good and acceptable profile of safety and effectiveness.

Palabras clave : Metastatic breast cancer; chemotherapy; taxanes..

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons